Professional Documents
Culture Documents
Coyden FT
Coyden FT
Coyden FT
COYDEN® 25%
(CLOPIDOL)
COYDEN® 25%
(clopidol)
3. PHARMACEUTICAL FORM
Premix for medicated feeding stuff.
4. PHARMACOLOGICAL PROPERTIES
Coyden® 25% manifests greatest anticoccidial activity during the early schizogonic
stages of coccidia life cycle - sporozoite and triphozoite phase (day 1-2). If the product is
administered more than 24 hours after invasion, its activity is considerably reduced.
When administered orally in the recommended doses, clopidol is absorbed by the
gastrointestinal tract, with maximum concentrations reached in liver and kidneys.
Therapeutic concentrations are maintained during the whole period of product
administration. Clopidol is excreted unchanged with urine and faeces.
5. CLINICAL PARTICULARS
5.3. Contraindications
Do not use in case of sensitivity to the active substance and/or to any of the excipients
of Coyden® 25%.
Do not feed to laying hens.
Do not feed clopidol to caged layer replacements after 16 weeks of age.
Do not administer clopidol to birds intended for breeding purposes.
3
COYDEN® 25%
(clopidol)
To aid in even distribution of Coyden® 25% in the finished feed, prepare a mixture of
Coyden® 25% in a portion of complete feed ingredient before mixing into the finished
ration. Blend the mixture with the remainder of the finished feed and mix thoroughly.
5.9. Overdose
Overdose may cause inappetence.
4
COYDEN® 25%
(clopidol)
6. PHARMACEUTICAL PARTICULARS
6.2. Incompatibilities
None known.